ArticleThe Journal of antimicrobial chemotherapy2020

Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.

Emmanuel Ndashimye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.